|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| A61K 38/18 | (2006.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 1/18 | (2006.01) | ||
| A61P 3/00 | (2006.01) | ||
| C07K 14/50 | (2006.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 3/08 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3321276 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17201957.2 |
| Date of filing the European patent application | 2012-09-26 | |
| (97) | Date of publication of the European application | 2018-05-16 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-28 |
| (46) | Date of publication of the claims translation | 2021-11-10 |
| (30) | Number | Date | Country code |
| 201161539280 P | 2011-09-26 | US |
| (72) |
BOETTCHER, Brian R. , US
CAPLAN, Shari L. , US
DANIELS, Douglas S. , US
HAMAMATSU, Norio , US
LICHT, Stuart , US
WELDON, Stephen Craig , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Sulieti baltymai, skirti metabolinių sutrikimų gydymui |
| FUSION PROTEINS FOR TREATING METABOLIC DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2025-08-27 | 14 | 289.00 EUR |
| 2026-09-26 |